Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

From TechCrunch

By Jagmeet Singh

March 15, 2023

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

HealthPlix, an Indian startup offering its in-house platform for doctors to help record patient data digitally, has raised $22 million in fresh investment to broaden its reach in the country and allow more doctors to utilize its software to offer improved care to their patients.

In India, roughly 300,000 doctors practice medicine regularly. However, this figure appears minuscule compared to the country’s rapidly expanding population. This has resulted in doctors not finding enough time to adequately assess each patient. HealthPlix wants to solve this problem through its platform, which is available in a freemium model.

The Bengaluru-based startup lets doctors create a 360-degree medical profile of their patients that can be helpful during consultations and for treating chronic diseases. The platform also offers a collective intelligence to doctors that helps them understand characteristics such as what diseases are cropping up in what areas and what treatment regimens are being used by different patients and doctors.

“We help doctors diagnose diseases earlier than otherwise they would by being their true assistant,” said Sandeep Gudibanda, co-founder and chief executive of HealthPlix, in an interview with TechCrunch.

Founded in 2017, the startup has already empowered more than 10,000 doctors who treat 2.5% of the country’s entire population using the proprietary software. It aims to serve over 25,000 doctors by 2024 and reach 50,000 by 2025 to treat nearly 15% of the Indian population. Of the total number of doctors on board, 70% are outside metro cities, HealthPlix said.

Gudibanda said HealthPlix handles a volume of 110,000 patients per day and has facilitated over 70 million consultations to date. The platform reaches about 334 towns in 28 states across the country.

Although the market of electronic medical record (EMR) platforms in India has a number of players that all claim to help doctors treat their patients efficiently, HealthPlix believes that its doctor-first approach gives it an edge over the competition.

“Every time you make a decision, whether it’s a small feature, a revenue opportunity, whether you build a tech stack or any decision you’re making, are you putting doctors first?” asked Chaitanya Raju, executive director at HealthPlix.

The startup targets doctors who own clinics and look for new-age solutions to enhance efficiency. This helps them get a wider reach as the country’s healthcare primarily is undertaken in small clinics and nursing homes instead of at large-scale hospitals, where Indian patients typically visit when their symptoms and illness have gotten worse.

Alongside giving a digital solution for keeping patient history and consultations, HealthPlix uses AI to make it easier for doctors to write prescriptions and search for appropriate medicines and diagnoses. The AI deployment also speeds up identifying patients based on their medical data and helps define critical elements that may be relevant for the patient or help the doctor during the treatment.

HealthPlix lets doctors write a long prescription of, say, 100 characters with just eight clicks instead of writing those characters manually, said Raju. Additionally, the platform offers translation of prescriptions to let patients easily understand what their doctors have prescribed them.

Approximately 60% of the prescriptions processed by HealthPlix are originally written in English by doctors. However, once printed, the prescriptions are automatically translated into the patient’s local language, Gudibanda said.

All the data available on the software is fully encrypted, and the startup’s modeling is only on anonymized data, Raju said.

The Series C round, led by Avataar Venture Partners and SIG Venture Capital, is divided into $20 million raise against equity and $2 million in debt. It also saw participation from existing investors including Lightspeed Venture Partners, JSW Ventures, Kalaari Capital and Chiratae Ventures.

“We have seen many business models that have failed to scale in the health-tech ecosystem, and we believe that Sandeep has built a great team to deliver on HealthPlix promise,” said Mohan Kumar, investment advisor to Avataar Venture Partners, in a prepared statement.

HealthPlix looks to utilize 80% of its fresh funding to grow the doctor base and invest more in sales, product and engineering teams. Currently, the startup has a headcount of 392 people. It will also invest in clinical decision support to help doctors treat the patients better. Moreover, it plans to explore a couple of models to explore how it can disrupt the insurance and the payer side, Gudibanda said.

“We invested in HealthPlix to help further the team’s vision of being the active catalyst for technology adoption in healthcare by allowing doctors to be more productive, thereby driving better outcomes for patients,” said Bhavani Rana, investment advisor, SIG Venture Capital.

Gudibanda said the startup’s revenues grew 3.5x over the last year and are expected to rise 2.5x to 3x next year. So far, HealthPlix has raised about $36 million. The valuation after the latest funding was not disclosed.

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery by Jagmeet Singh originally published on TechCrunch

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

HealthPlix, an Indian startup offering its in-house platform for doctors to help record patient data digitally, has raised $22 million in fresh investment to broaden its reach in the country and allow more doctors to utilize its software to offer improved care to their patients. In India, roughly 300,000 doctors practice medicine regularly. However, this […]

Mar 14, 2023

Lotus Health nabs $35M for AI doctor that sees patients for free

Lotus Health nabs $35M for AI doctor that sees patients for free

This AI doctor is licensed in all 50 states, the startup says. The deal was led by CRV and Kleiner Perkins.

Feb 3, 2026

Innovaccer aims to become healthcare’s AI powerhouse with $275M Series F

Innovaccer aims to become healthcare’s AI powerhouse with $275M Series F

When it comes to data, perhaps no sector has as much of it and in as many distinct silos as the healthcare industry. Hundreds of millions of patient records reside within various electronic health records (EHRs) maintained by vendors like Epic, Cerner and Athena. Insurance companies hold extensive data sets on coverage, reimbursement rates, and patient demographics. Pharmacies and laboratories contribute further data points on medication usage and diagnostic results. Over the last decade or so

Jan 9, 2025

Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany

Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany

Patient21, a four-year-old German startup that combines a digital healthcare platform with real-world brick-and-mortar clinics, has raised €100 million ($108 million) in a Series C round of funding led by Israeli VC firm Pitango, constituting a mix of equity and debt. Founded out of Berlin in 2019, Patient21’s platform spans pretty much the whole patient […]

May 21, 2023

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

India’s HealthPlix raises $22M to accelerate growth and enhance healthcare delivery

HealthPlix, an Indian startup offering its in-house platform for doctors to help record patient data digitally, has raised $22 million in fresh investment to broaden its reach in the country and allow more doctors to utilize its software to offer improved care to their patients. In India, roughly 300,000 doctors practice medicine regularly. However, this […]

Mar 14, 2023

Lotus Health nabs $35M for AI doctor that sees patients for free

Lotus Health nabs $35M for AI doctor that sees patients for free

This AI doctor is licensed in all 50 states, the startup says. The deal was led by CRV and Kleiner Perkins.

Feb 3, 2026

Innovaccer aims to become healthcare’s AI powerhouse with $275M Series F

Innovaccer aims to become healthcare’s AI powerhouse with $275M Series F

When it comes to data, perhaps no sector has as much of it and in as many distinct silos as the healthcare industry. Hundreds of millions of patient records reside within various electronic health records (EHRs) maintained by vendors like Epic, Cerner and Athena. Insurance companies hold extensive data sets on coverage, reimbursement rates, and patient demographics. Pharmacies and laboratories contribute further data points on medication usage and diagnostic results. Over the last decade or so

Jan 9, 2025

Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany

Patient21, a digital healthcare startup with brick-and-mortar clinics, raises $108M to grow beyond Germany

Patient21, a four-year-old German startup that combines a digital healthcare platform with real-world brick-and-mortar clinics, has raised €100 million ($108 million) in a Series C round of funding led by Israeli VC firm Pitango, constituting a mix of equity and debt. Founded out of Berlin in 2019, Patient21’s platform spans pretty much the whole patient […]

May 21, 2023